Becker's Healthcare November 14, 2024
Alexandra Murphy

Amid a decade-high surge in drug shortages, the American Medical Association has adopted new policy measures aimed at addressing the crisis.

The policy advocates for federal oversight of compounding pharmacies advertising drugs that are in shortage, the prevention of artificial drug shortages and the introduction of incentives to encourage manufacturers to invest in improving product processes.

A key focus of the AMA’s policy is the shortage of semaglutide and other GLP-1s, which have faced increased demand due to aggressive advertising, particularly...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma, Pharma / Biotech, Physician, Provider
Happy Holidays: Is Your Doctor Happy? Are You Happy With Your Doctor?
Telehealth gets short extension, physician pay is cut in spending bill
AI’s cognitive gap: Why human doctors remain irreplaceable
Memory Loss Is Not Always Dementia. A Neurologist Explains
HIMSSCast: Research as restorative physician medicine

Share This Article